Related Experiment Videos
Ceftazidime concentration in gallbladder tissue and excretion in bile
K Shiramatsu1, K Hirata, T Yamada
1First Department of Surgery, Sapporo Medical College, Hokkaidou, Japan.
Antimicrobial Agents and Chemotherapy
|October 1, 1988
Summary
Ceftazidime effectively treats biliary tract infections. This study measured ceftazidime concentrations in bile and gallbladder tissue for patients with gallstones, confirming its therapeutic potential.
Area of Science:
- Pharmacology
- Infectious Diseases
- Gastroenterology
Background:
- Biliary tract infections (BTIs) are common complications of cholelithiasis.
- Effective antibiotic penetration into bile and gallbladder tissue is crucial for treating BTIs.
- Ceftazidime is a broad-spectrum cephalosporin with potential utility in managing these infections.
Purpose of the Study:
- To evaluate the efficacy of ceftazidime in patients with cholelithiasis.
- To determine ceftazidime concentrations in bile and gallbladder wall tissue.
- To assess the potential of ceftazidime as a treatment for biliary tract infections.
Main Methods:
- Ceftazidime was administered to 16 patients diagnosed with cholelithiasis.
- Concentrations of ceftazidime were measured in bile samples.
- Ceftazidime levels were also quantified in gallbladder wall tissue biopsies.
Main Results:
- The study successfully measured ceftazidime concentrations in both bile and gallbladder wall tissue.
- The data indicate significant penetration of ceftazidime into these relevant anatomical sites.
- These findings support the antimicrobial activity of ceftazidime in the context of biliary pathology.
Conclusions:
- Ceftazidime demonstrates promising efficacy for treating biliary tract infections.
- Adequate drug concentrations achieved in bile and gallbladder tissue suggest therapeutic effectiveness.
- Further clinical trials are warranted to establish ceftazidime as a standard treatment for BTIs in patients with gallstones.